2021 Speakers

Speakers

James Cai
Vice President, Global Drug Development & Head of China R&D
BRISTOL-MYERS SQUIBB
Maggie Chang
Vice President, Drug Regulatory Policy
TIGERMED
Feng Chen
Professor of Statistics & Dean of Graduate School
NANJING MEDICAL UNIVERSITY
PJ Chen
Co-Founder & Chief Executive Officer
CALI BIOSCIENCES
Sharon Chen
Co-Chief Executive Officer
YAOCHENG HEALTHCARE TECHNOLOGY
Xiao Cheng
Director, Clinical Trials Center
SHANGHAI SIXTH PEOPLE'S HOSPITAL
Paul Dai
Head of Clinical Science, TDC Asia
TAKEDA
Jieying Fu
Regulatory Affairs Head
I-MAB BIOPHARMA
Xiaoning Guo
Vice President, Head of R&D and Chief Medical Officer
SCICLONE PHARMACEUTICALS
Ye Hua
Chairman & Chief Executive Officer
BIONOVA PHARMACEUTICALS
Frank Jiang
Chairman & Chief Executive Officer
CSTONE PHARMA
Helen Jiang
Chief Medical Officer
ZHEJIANG YANGSHENGTANG BIOTECH
Michael Jiang
Head of Strategic Initiatives & Scientific Relations China
SANOFI
James Li
Co-founder, Chairman of the Board & Chief Executive Officer
JW THERAPEUTICS
Simon Li
Chief Medical Officer
SIRONAX
Joyce Liu
Vice President, Head of Regulatory Affairs, Greater China
TAKEDA
Janet Lv
Regulatory Head of Asia Pacific
ROCHE
Bin Peng
Chief Medical Officer
EPIMAB BIOTHERAPEUTICS
Joan Shen
Chief Executive Officer
I-MAB BIOPHARMA
Jonathan Wang
Executive Vice President, Head of Business Development
ZAI LAB
Jonathan Wang
Chairman & Chief Executive Officer
INMAGENE BIOPHARMACEUTICALS
Li Wang
Senior Vice President, Head of Drug Development & Medical Affairs Center
LILLY CHINA
Richard Wang
Founder & Chief Executive Officer
NEUKIO BIOTHERAPEUTICS
Zaiqi Wang
Chairman & Chief Executive Officer
INXMED
Yan Wu
Chief Medical Officer
ARK BIOSCIENCES
Jielai Xia
Director, Health Statistics
AIR FORCE MEDICAL UNIVERSITY
Chen Yao
Director, Medical Statistics
PEKING UNIVERSITY FIRST HOSPITAL
Weian Yuan
Director, Clinical Trials Center
SHUGUANG HOSPITAL
Fangning Zhang
Partner
MCKINSEY & COMPANY
Wei Zhang
Vice President, Clinical Development & Medical, Greater China
BOEHRINGER INGELHEIM